TickerFactsScreenerDevelopers

Emergent BioSolutions Inc. (EBS) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $126.30M2017: $187.70M2018: $322.30M2019: $433.50M2020: $537.00M2021: $748.10M2022: $693.10M2023: $705.40M2024: $681.30M2025: $326.20M$326.20M
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$326.20M-52.1%
2024$681.30M-3.4%
2023$705.40M+1.8%
2022$693.10M-7.4%
2021$748.10M+39.3%
2020$537.00M+23.9%
2019$433.50M+34.5%
2018$322.30M+71.7%
2017$187.70M+48.6%
2016$126.30M—